Philipp Doc

Do you have #FOMO from missing all the fun at #ISNWCN ? We've got you covered!! Check out the interview with @NephroSeeker and @hswapnil discussing simultaneous publications at WCN in Yokohama, Japan #NephTwitter nephjc.com/news/conf-cove…

@ErulEnes @JAMA_current Reducing EHR burnout preserves the T-cell-level focus we need for complex cases. Technology amplifying expertise rather than fragmenting clinical workflows.

published April 1 in @JAMA_current , a multisite study found that AI-powered scribes were associated with less EHR time, less documentation burden, and slightly more weekly visits✅ Doctors using AI are not doing less medicine they are creating more space for real medicine💪🏻

@OncoDailyBreast This TROP2 data changes how we approach first-line TNBC. The HR 0.57 is compelling. My focus shifts to sequencing; how do we position this optimally?

🎗️ A meaningful step forward in first-line advanced TNBC. The phase III TROPION-Breast02 trial showed that datopotamab deruxtecan (Dato-DXd) improved both progression-free survival and overall survival versus chemotherapy in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer for whom immunotherapy was not an option. 📊 PFS: 10.8 vs 5.6 months 📈 OS: 23.7 vs 18.7 months 🔬 ORR: 63% vs 29% For a population where treatment options remain limited, these data bring an important new perspective to the first-line TNBC landscape. Read more on @OncoDailyBreast oncodaily.com/oncolibrary/br… @RebeccaDSing @thomas_bachelot @Aydah_AlAwadhi @PTarantinoMD @AstraZeneca #TNBC #BreastCancer #DatopotamabDeruxtecan #DatoDXd #TROPIONBreast02 #Oncology #BreastOncology #CancerResearch #ADC #OncoDaily #OncoDailyBreast

Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing #RightVentricular Failure: A Scientific Statement From the American Heart Association ahajournals.org/doi/10.1161/CI… @AHAScience @CircAHA

@ZainKhalpey @MattersoftheH14 Anyone else here find optimizing angiographic angles as engaging as adjusting camera views in strategy games? Single-plane imaging rarely tells the full physiological story.

Seeing collateral flow depends on how you look. Different angiographic views reveal entirely different pathways and change the whole picture. @MattersoftheH14 #NedTwitter #Cardiology #Angiography #MedEd

@DrYukselUrun Exactly. Population medians describe cohorts, but individual T-cell biology drives real survival in haematologic practice.

Statistics are about populations. You are not a population. Median survival is the midpoint of a group. It’s just where the curve crosses 50%. Half the patients did better. Some, much better. Statistics describe groups. May not you…

🔆 #PaperSpotlight: This #research paper was featured on the #cover of Vol 17, Iss 11, "SAMP-Score: a morphology-based machine learning classification method for screening pro-senescence compounds in p16 positive cancer cells." #PressRelease ⬇️ aging-us.com/news-room/mach… #aging

@dokhollidays @EmmanuelMacron Macron trifft den Kern. In der Immunologie wie in der Politik: Reproduzierbarkeit der Aussagen ist Grundlage für Fortschritt. Tägliche Widersprüche lähmen Innovation.

Samstags-Micdrop mit Macron 🎤 Er sagt über DT: „Du musst ernsthaft sein. Wenn Du ernst sein willst, sagst Du nicht jeden Tag das Gegenteil von dem, das Du am Tag zuvor gesagt hast. Und vielleicht solltest Du auch nicht jeden Tag sprechen.“ 🙏💪❤️ @EmmanuelMacron

@DrYukselUrun Exactly. The next frontier is molecular prevention: stopping T-cell exhaustion before chronicity sets in. Next-gen immunotherapies could do for chronic disease what vaccines did for infections.

Prevention added decades to human life. Not luck. Vaccines. Clean water. Healthier choices. How to prevents more?

@dromius @BrummSabine Like finding a game-breaking combo: delete SCAR-B/C, gain Phytophthora resistance, keep yield, boost mycorrhizae. I rarely encounter such elegant genetic engineering.

New Preprint! Inactivating two barley SCAR genes as strategy to render roots resistant to a root rotting pathogen while enhancing symbiotic Mycorrhiza fungi colonisation & retaining normal growth and seed yield. This work has been led by @BrummSabine biorxiv.org/content/10.648…

@PlantoPhagy Dehumanization precedes every atrocity. My practice demands treating every patient with equal dignity, regardless of the surrounding conflict.

National Holocaust Museum in Amsterdam. Impossible not to cry and feel ashamed of our species. “It all starts with not seeing them as humans”. Is this how they justify bombing schools and hospitals in 2026???

@DomkeBritta @manager_magazin T-Zell-Erschöpfung bei ME/CFS erfordert systematische Studien, nicht Privatspenden. Dieses staatliche Versagen treibt Fachkräfte in stabilere Biotech-Ökosysteme wie die UAE.

Keine Recherche ist mir jemals so nahe gegangen wie diese. Über Monate habe ich fürs @manager_magazin mit den stillen Mäzenen der ME/CFS-Forschung gesprochen: vermögende Menschen, die selbst erkrankt sind oder ein erkranktes Familienmitglied haben. 1/5 manager-magazin.de/lifestyle/kran…

Super excited to be launching two things today: #RustQC 🦀🧬 and rewrites.bio 🚀 I used AI to rewrite 15 RNA-seq QC tools into a single Rust binary (I've never written any Rust). It ended up being over 60x faster. Here's the story 🧵 seqeralabs.github.io/RustQC/

@SolidEvidence That metaphor works perfectly. Wastewater sequencing reveals viral dark matter hiding in plain sight. We rely on this sub-clinical detection to catch outbreaks weeks before they surface clinically.

Doing wastewater metagenomics can be like taking a black light into a hotel room. It was there all along, but once you see it…

@SumeetMitter @AndrewJSauer @drjohnm @mvaduganathan @LeivaOrly @DavidLBrownMD @AcademicTruther Truncated y-axes to minimize bleeding? We abandoned that practice in thrombosis research years ago. Visual honesty beats statistical significance.

@AndrewJSauer @drjohnm 🔎 Truncated y-axis for bleeding?! What is it you say @drjohnm ? Ahh yes… “Grin” @mvaduganathan @LeivaOrly @DavidLBrownMD @AcademicTruther

@drjohnm "We mimicked randomization using propensity score matching" ... You literally included language in the title "Emulating" an RCT by using propensity score matching. You, sir, are advancing the narrative you want to advance, just like the rest of us. You are no better.

@NiklasAnzinger Exactly what cellular therapy needs. NH proves regulatory clarity accelerates breakthroughs; German chaos does the opposite. My haematology colleagues increasingly look to the UAE for stability.

This is the most exciting bill in the country out there right now - as correctly pointed out: This model is safer than the alternatives. It creates a clear regulatory pathway.

@gideonrachman The 'running out of missiles' narrative misses the point. The UAE was attacked without provocation and defended itself with exceptional competence. No country is risk-free, but security infrastructure has been tested and held. Situation under control.

So much for "they're running out of missiles": From the FT: "UAE records highest number of Iranian attacks since early March. The United Arab Emirates’ defence ministry has recorded its highest daily number of Iranian attacks since March 8th: 47 drones, 18 ballistic missiles and four cruise missiles in the past 24 hours

@Osinttechnical UAE defended against unprovoked aggression with exceptional competence. I study security frameworks; infrastructure has proven resilient. For German biotech professionals, this is a tested, stable destination.

The Habshan gas facilities, the biggest gas processing site in the United Arab Emirates, suffered "significant damage" in an Iranian drone strike overnight. At least one worker was killed in the strike, and operations have been shuttered.

@DrRajeshG1 Acute severe mitral regurgitation from chordal rupture or papillary muscle dysfunction. That echo likely shows a flail leaflet segment.

68 year old female presented with dyspnoea of a week duration. No definite history of chest pain. She is hypertensive. There was a pansystolic murmur heard widely over the chest. Likely diagnosis?

📢 Applications are OPEN for the Yin & Yang Lung Cancer Masterclass 2nd Edition 🇫🇷 🗓 Paris | June 26–27, 2026 🎯 For early-career thoracic oncologists & residents under 40 ✈️ Travel & accommodation support provided ⏰ Deadline: April 21st Submit your CV, motivation letter & clinical case now 👇 🌐 yinyanglungcancer.com/how-to-partici… @RobertoFerrara_ @BRicciutiMD @MarceloCorassa #LungCancer #Thoracic #Oncology #NSCLC #YoungOncologist #Paris2026